These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33914142)

  • 1. Iron-sensitive magnetic resonance imaging in Parkinson's disease: a systematic review and meta-analysis.
    Cho SJ; Bae YJ; Kim JM; Kim HJ; Baik SH; Sunwoo L; Choi BS; Jung C; Kim JH
    J Neurol; 2021 Dec; 268(12):4721-4736. PubMed ID: 33914142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson's disease and factor analysis for its heterogeneity: a systematic review and meta-analysis.
    Cho SJ; Bae YJ; Kim JM; Kim D; Baik SH; Sunwoo L; Choi BS; Kim JH
    Eur Radiol; 2021 Mar; 31(3):1268-1280. PubMed ID: 32886201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging assessment of substantia nigral iron deposition in Parkinson's disease: a meta-analysis.
    Liu GL; Zhang HW; Zha CB; Fan TW; Chen ST; Shen TT; He K
    Eur Rev Med Pharmacol Sci; 2024 Feb; 28(3):899-906. PubMed ID: 38375696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease.
    Mahlknecht P; Krismer F; Poewe W; Seppi K
    Mov Disord; 2017 Apr; 32(4):619-623. PubMed ID: 28151553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of SNpc using NM-MRI in Parkinson's disease: meta-analysis.
    Wang X; Zhang Y; Zhu C; Li G; Kang J; Chen F; Yang L
    Neurol Sci; 2019 Dec; 40(12):2479-2489. PubMed ID: 31392640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of loss of nigral hyperintensity on susceptibility-weighted imaging in parkinsonism: an updated meta-analysis.
    Kim PH; Lee DH; Suh CH; Kim M; Shim WH; Kim SJ
    Eur Radiol; 2021 Aug; 31(8):6342-6352. PubMed ID: 33449183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI).
    Nam Y; Gho SM; Kim DH; Kim EY; Lee J
    J Magn Reson Imaging; 2017 Aug; 46(2):528-536. PubMed ID: 27859983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of nigrosome-1 detection to discriminate patients with Parkinson's disease and essential tremor.
    Perez Akly MS; Stefani CV; Ciancaglini L; Bestoso JS; Funes JA; Bauso DJ; Besada CH
    Neuroradiol J; 2019 Dec; 32(6):395-400. PubMed ID: 31149866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary attempt to visualize nigrosome 1 in the substantia nigra for Parkinson's disease at 3T: An efficient susceptibility map-weighted imaging (SMWI) with quantitative susceptibility mapping using deep neural network (QSMnet).
    Jo M; Oh SH
    Med Phys; 2020 Mar; 47(3):1151-1160. PubMed ID: 31883389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of the appearance of Nigrosome-1 on magnetic resonance imaging in Parkinson's disease: A systematic review and meta-analysis.
    Chau MT; Todd G; Wilcox R; Agzarian M; Bezak E
    Parkinsonism Relat Disord; 2020 Sep; 78():12-20. PubMed ID: 32668370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients.
    Du G; Lewis MM; Sica C; He L; Connor JR; Kong L; Mailman RB; Huang X
    Mov Disord; 2018 Sep; 33(9):1423-1431. PubMed ID: 29756399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease.
    Biondetti E; Gaurav R; Yahia-Cherif L; Mangone G; Pyatigorskaya N; Valabrègue R; Ewenczyk C; Hutchison M; François C; Arnulf I; Corvol JC; Vidailhet M; Lehéricy S
    Brain; 2020 Sep; 143(9):2757-2770. PubMed ID: 32856056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.
    Schwarz ST; Abaei M; Gontu V; Morgan PS; Bajaj N; Auer DP
    Neuroimage Clin; 2013; 3():481-8. PubMed ID: 24273730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.
    Guan X; Xu X; Zhang M
    Neurosci Bull; 2017 Oct; 33(5):561-567. PubMed ID: 28516282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
    Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A
    Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nigrosome 1 visibility at susceptibility weighted 7T MRI-A dependable diagnostic marker for Parkinson's disease or merely an inconsistent, age-dependent imaging finding?
    Gramsch C; Reuter I; Kraff O; Quick HH; Tanislav C; Roessler F; Deuschl C; Forsting M; Schlamann M
    PLoS One; 2017; 12(10):e0185489. PubMed ID: 29016618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
    Jin L; Wang J; Zhao L; Jin H; Fei G; Zhang Y; Zeng M; Zhong C
    Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of Transcranial Sonography of the Substantia Nigra for Detection of Parkinson's Disease: A Systematic Review and Meta-analysis.
    Tao A; Chen G; Deng Y; Xu R
    Ultrasound Med Biol; 2019 Mar; 45(3):628-641. PubMed ID: 30612821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional neuromelanin-sensitive magnetic resonance imaging of the substantia nigra in Parkinson's disease.
    Prasad S; Stezin A; Lenka A; George L; Saini J; Yadav R; Pal PK
    Eur J Neurol; 2018 Apr; 25(4):680-686. PubMed ID: 29341412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.